Silo Pharma Stock Current Liabilities
| SILO Stock | USD 1.85 0.03 1.60% |
Silo Pharma fundamentals help investors to digest information that contributes to Silo Pharma's financial success or failures. It also enables traders to predict the movement of Silo OTC Stock. The fundamental analysis module provides a way to measure Silo Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Silo Pharma otc stock.
Silo |
Silo Pharma OTC Stock Current Liabilities Analysis
Silo Pharma's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
In accordance with the recently published financial statements, Silo Pharma has a Current Liabilities of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The current liabilities for all United States stocks is 100.0% higher than that of the company.
Silo Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Silo Pharma's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Silo Pharma could also be used in its relative valuation, which is a method of valuing Silo Pharma by comparing valuation metrics of similar companies.Silo Pharma is currently under evaluation in current liabilities category among related companies.
Silo Fundamentals
| Return On Equity | -0.44 | ||||
| Return On Asset | -0.25 | ||||
| Operating Margin | (53.47) % | ||||
| Current Valuation | (2.06 M) | ||||
| Shares Outstanding | 2.84 M | ||||
| Shares Owned By Insiders | 6.34 % | ||||
| Shares Owned By Institutions | 5.60 % | ||||
| Number Of Shares Shorted | 61.39 K | ||||
| Price To Earning | 118.39 X | ||||
| Price To Book | 0.93 X | ||||
| Price To Sales | 77.69 X | ||||
| Revenue | 72.1 K | ||||
| Gross Profit | 66.26 K | ||||
| EBITDA | (3.86 M) | ||||
| Net Income | (3.63 M) | ||||
| Cash And Equivalents | 8.85 M | ||||
| Cash Per Share | 4.45 X | ||||
| Current Ratio | 33.28 X | ||||
| Book Value Per Share | 2.12 X | ||||
| Cash Flow From Operations | (3.22 M) | ||||
| Short Ratio | 0.46 X | ||||
| Earnings Per Share | (1.18) X | ||||
| Target Price | 10.0 | ||||
| Beta | 1.35 | ||||
| Market Capitalization | 5.6 M | ||||
| Total Asset | 7.75 M | ||||
| Retained Earnings | (10.87 M) | ||||
| Working Capital | 6.91 M | ||||
| Net Asset | 7.75 M |
About Silo Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Silo Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Silo Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Silo Pharma based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Silo Pharma. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Complementary Tools for Silo OTC Stock analysis
When running Silo Pharma's price analysis, check to measure Silo Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Silo Pharma is operating at the current time. Most of Silo Pharma's value examination focuses on studying past and present price action to predict the probability of Silo Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Silo Pharma's price. Additionally, you may evaluate how the addition of Silo Pharma to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |